Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Msci Em Europe Middle East Africa Esg Swap UCITS ETF 1c
LU0292109005 · LU0292109005 · USD · domicile Luxembourg
Equity · Emerging markets · Sustainable / ESGSFDR art. 8
Index tracked: MSCI EM EMEA Low Carbon SRI Selection Capped Index (USD)
- TER
- 0.65%+ trans. 0.00%
- Fund size
- 45 m EUR
- Tracking difference
- −0.87%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 19 Jun 2007 · costs from the KID as of 2 Sept 2026 · 42 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the MSCI EM EMEA Low Carbon SRI Selection Capped Index (index) which is designed to reflect the performance of companies that have lower current and potential carbon exposure than that of the broader equity market in European, Middle Eastern and African emerging markets, and have high ESG performance.
DESCRIPTION OF INDEX:
The Index applies two sets of rules independently, Lowest Carbon Exposure Selection Rules and Highest ESG Performance…
Performance since series start (in euro) — base 100
19 Jun 2007 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +24.9% |
| 3 years | +72.8% |
| 5 years | +64.4% |
| 10 years | +92.8% |
| Since series start | +88.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 21.67% | 17.91% | 18.46% |
| Max drawdown | −16.21% | −16.21% | −28.62% |
| Sharpe | 0.95 | 1.06 | 0.48 |
| Sortino | 1.49 | 1.63 | 0.70 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0292109005 · LU02921090051
RebalixLU0292109005 · LU0292109005 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +42.07% | +43.16% | −1.09% |
| 2024 | +10.01% | +10.74% | −0.73% |
| 2023 | +8.98% | +9.78% | −0.80% |
| 2022 | −10.07% | −9.38% | −0.69% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 42 securities · top-10 weight = 52.5%
| Top holdings | Weight |
|---|---|
| 8.6% | |
| 7.7% | |
| 6.5% | |
| 6.3% | |
| 5.8% | |
| 3.7% | |
| 3.7% | |
| 3.4% | |
| 3.4% | |
| 3.4% |
Listing venues
ESMA register (FIRDS) and official exchange lists
XMEA · Borsa Italiana (ETFplus), Xetra (Deutsche Börse)
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 17 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU0292109005
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0292109005
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU0292109005 · LU02921090052